» Authors » Ilenia Segatto

Ilenia Segatto

Explore the profile of Ilenia Segatto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 367
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Segatto I, Baldassarre G, Belletti B
Int J Mol Sci . 2018 Sep; 19(9). PMID: 30231553
Signal transducer and activator of transcription 3 (STAT3) is responsible for mediating the transcriptional programs downstream of several cytokine, growth factor, and oncogenic stimuli. Its expression and activity are consistently...
22.
Cusan M, Mungo G, De Marco Zompit M, Segatto I, Belletti B, Baldassarre G
Front Endocrinol (Lausanne) . 2018 Aug; 9:393. PMID: 30065701
The gene encodes for the p27 protein, firstly characterized as a cyclin dependent kinase (CDK)-inhibitor. Germline pathogenic variants have been described in hereditary tumors, such as multiple endocrine neoplasia (MEN)-like...
23.
Berton S, Cusan M, Segatto I, Citron F, DAndrea S, Benevol S, et al.
Sci Rep . 2017 Apr; 7(1):595. PMID: 28377607
Genomic instability represents a typical feature of aggressive cancers. Normal cells have evolved intricate responses to preserve genomic integrity in response to stress, such as DNA damage induced by γ-irradiation....
24.
Pellizzari I, Fabris L, Berton S, Segatto I, Citron F, DAndrea S, et al.
Oncotarget . 2016 Sep; 7(40):64560-64574. PMID: 27579539
The tumor suppressor protein p27Kip1 plays a pivotal role in the control of cell growth and metastasis formation.Several studies pointed to different roles for p27Kip1 in the control of Ras...
25.
Segatto I, Massarut S, Boyle R, Baldassarre G, Walker D, Belletti B
Aging (Albany NY) . 2016 May; 8(5):958-76. PMID: 27155197
Unlabelled: Breast cancer is a frequent and treatable disease. However, when recurrent, breast cancer often becomes refractory to therapy and progresses into metastatic forms that are typically incurable. Thus, understanding...
26.
Fabris L, Berton S, Pellizzari I, Segatto I, DAndrea S, Armenia J, et al.
Proc Natl Acad Sci U S A . 2015 Oct; 112(45):13916-21. PMID: 26512117
The cyclin-dependent kinase (CDK) inhibitor p27(kip1) is a critical regulator of the G1/S-phase transition of the cell cycle and also regulates microtubule (MT) stability. This latter function is exerted by...
27.
Baldassarre G, Segatto I, Belletti B
Aging (Albany NY) . 2015 Aug; 7(8):531-2. PMID: 26298846
No abstract available.
28.
Berton S, Pellizzari I, Fabris L, DAndrea S, Segatto I, Canzonieri V, et al.
Cell Cycle . 2014 Dec; 13(19):3100-11. PMID: 25486569
The CDK inhibitor p27(kip1) is a critical regulator of cell cycle progression, but the mechanisms by which p27(kip1) controls cell proliferation in vivo are still not fully elucidated. We recently...
29.
Segatto I, Berton S, Sonego M, Massarut S, Perin T, Piccoli E, et al.
Oncotarget . 2014 Jul; 5(15):6267-79. PMID: 25026286
Inflammation is clinically linked to cancer but the mechanisms are not fully understood. Surgery itself elicits a range of inflammatory responses, suggesting that it could represent a perturbing factor in...
30.
Armenia J, Fabris L, Lovat F, Berton S, Segatto I, DAndrea S, et al.
Oncotarget . 2014 Apr; 5(5):1185-97. PMID: 24727437
MicroRNAs (miRs) are a large class of small regulatory RNAs that function as nodes of signaling networks. This implicates that miRs expression has to be finely tuned, as observed during...